Encapsulation and Delivery of Crystalline Hydrophobic Nutraceuticals Using Nanoemulsions: Factors Affecting Polymethoxyflavone Solubility

Overview

Journal Food Biophys

Specialty Biophysics

Date 2013 May 7

PMID 23646037

Citations 2

Authors

Yan Li

Hang Xiao

David Julian McClements

Affiliations

Soon will be listed here.

Abstract

Polymethoxyflavones (PMF) isolated from citrus peel have potent anti-cancer activity, however their utilization as functional ingredients in foods is currently limited because of their high melting point and poor water-solubility. The influence of oil type and concentration, hydrophilic polymer addition, and simulated intestinal conditions on PMF (5-hydroxytangeretin) solubility in solutions and nanoemulsions was examined. The saturation concentration of PMF in water was relatively low (0.93 µM), but could be increased appreciably by adding certain hydrophilic polymers: polyethylene glycol (PEG) and β-cyclodextrin (CD) were ineffective at increasing solubility, but poly(vinyl alcohol) (PVA) and hydroxypropyl methylcellulose (HPMC) greatly enhanced solubility (., > 6 µM for 0.5 % polymer). PMF was more soluble in medium chain triglycerides (MCT, 6.1 mM) than long chain triglycerides (LCT, 4.2 mM). The encapsulation efficiency of PMF in oil-in-water nanoemulsions was higher when MCT was used as the oil phase rather than LCT, and could be increased by increasing the oil droplet content. The solubility of PMF in simulated small intestinal fluids was increased by solubilization in bile micelles and mixed micelles formed during lipid digestion. These results have important implications for the development of functional foods fortified with bioactive hydrophobic components aimed at improving human health and wellness.

Citing Articles

Disruption of biological membranes by hydrophobic molecules: a way to inhibit bacterial growth.

Valdez-Lara A, Jaramillo-Granada A, Ortega-Zambrano D, Garcia-Marquez E, Garcia-Fajardo J, Mercado-Uribe H Front Microbiol. 2025; 15():1478519.

PMID: 39845054 PMC: 11750777. DOI: 10.3389/fmicb.2024.1478519.

Ultrasound-assisted pH-shifting to construct a stable aqueous solution of paprika oleoresin using egg yolk low-density lipoprotein as a natural liposome-like nano-emulsifier.

Ye H, Wang B, Xiao D, Li H, Wu D, Wang J Ultrason Sonochem. 2023; 98:106477.

PMID: 37327687 PMC: 10422104. DOI: 10.1016/j.ultsonch.2023.106477.

Improved bioaccessibility of polymethoxyflavones loaded into high internal phase emulsions stabilized by biopolymeric complexes: A dynamic digestion study via TNO's gastrointestinal model.

Wijaya W, Zheng H, Zheng T, Su S, Patel A, van der Meeren P Curr Res Food Sci. 2020; 2:11-19.

PMID: 32914106 PMC: 7473367. DOI: 10.1016/j.crfs.2019.11.007.

References

Muller R, Keck C . Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol. 2004; 113(1-3):151-70. DOI: 10.1016/j.jbiotec.2004.06.007. View

Porter C, Wasan K, Constantinides P . Lipid-based systems for the enhanced delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 2007; 60(6):615-6. DOI: 10.1016/j.addr.2007.10.009. View

McClements D . Crystals and crystallization in oil-in-water emulsions: implications for emulsion-based delivery systems. Adv Colloid Interface Sci. 2012; 174:1-30. DOI: 10.1016/j.cis.2012.03.002. View

Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S . Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011; 420(1):1-10. DOI: 10.1016/j.ijpharm.2011.08.032. View

Tian Y, Mao S . Amphiphilic polymeric micelles as the nanocarrier for peroral delivery of poorly soluble anticancer drugs. Expert Opin Drug Deliv. 2012; 9(6):687-700. DOI: 10.1517/17425247.2012.681299. View

Bevernage J, Forier T, Brouwers J, Tack J, Annaert P, Augustijns P . Excipient-mediated supersaturation stabilization in human intestinal fluids. Mol Pharm. 2011; 8(2):564-70. DOI: 10.1021/mp100377m. View

Tajarobi F, Larsson A, Matic H, Abrahmsen-Alami S . The influence of crystallization inhibition of HPMC and HPMCAS on model substance dissolution and release in swellable matrix tablets. Eur J Pharm Biopharm. 2010; 78(1):125-33. DOI: 10.1016/j.ejpb.2010.11.020. View

Alhnan M, Murdan S, Basit A . Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability. Int J Pharm. 2011; 416(1):55-60. DOI: 10.1016/j.ijpharm.2011.05.079. View

Kohno H, Yoshitani S, Tsukio Y, Murakami A, Koshimizu K, Yano M . Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Life Sci. 2001; 69(8):901-13. DOI: 10.1016/s0024-3205(01)01169-9. View

10.

Thakkar S, Maziya-Dixon B, Dixon A, Failla M . Beta-carotene micellarization during in vitro digestion and uptake by Caco-2 cells is directly proportional to beta-carotene content in different genotypes of cassava. J Nutr. 2007; 137(10):2229-33. DOI: 10.1093/jn/137.10.2229. View

11.

Dong P, Qiu P, Zhu Y, Li S, Ho C, McClements D . Simultaneous determination of four 5-hydroxy polymethoxyflavones by reversed-phase high performance liquid chromatography with electrochemical detection. J Chromatogr A. 2009; 1217(5):642-7. DOI: 10.1016/j.chroma.2009.11.097. View

12.

Mitchell S, Reynolds T, Dasbach T . A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose. Int J Pharm. 2002; 250(1):3-11. DOI: 10.1016/s0378-5173(02)00293-4. View

13.

Porter C, Charman W . In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev. 2001; 50 Suppl 1:S127-47. DOI: 10.1016/s0169-409x(01)00182-x. View

14.

Li S, Pollock-Dove C, Dong L, Chen J, Creasey A, Dai W . Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study. Mol Pharm. 2012; 9(5):1100-8. DOI: 10.1021/mp200352q. View

15.

Bevernage J, Brouwers J, Clarysse S, Vertzoni M, Tack J, Annaert P . Drug supersaturation in simulated and human intestinal fluids representing different nutritional states. J Pharm Sci. 2010; 99(11):4525-34. DOI: 10.1002/jps.22154. View

16.

Wang J, Hou T . Recent advances on aqueous solubility prediction. Comb Chem High Throughput Screen. 2011; 14(5):328-38. DOI: 10.2174/138620711795508331. View

17.

Li Y, Zheng J, Xiao H, McClements D . Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallization. Food Hydrocoll. 2012; 27(2):517-528. PMC: 3367464. DOI: 10.1016/j.foodhyd.2011.08.017. View

18.

Gao P, Rush B, Pfund W, Huang T, Bauer J, Morozowich W . Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003; 92(12):2386-98. DOI: 10.1002/jps.10511. View

19.

Lai C, Li S, Chai C, Lo C, Dushenkov S, Ho C . Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin. Carcinogenesis. 2008; 29(12):2415-24. DOI: 10.1093/carcin/bgn222. View

20.

Kleberg K, Jacobsen J, Mullertz A . Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies. J Pharm Pharmacol. 2010; 62(11):1656-68. DOI: 10.1111/j.2042-7158.2010.01023.x. View